Breast Cancer Treatment Surgeon Knoxville, TN - Dr. Aaron Margulies  FACS
  • Email
  • Facebook
  • Google
  • Linkedin
  • Pinterest
  • Twitter
  • Youtube
  • Rss
Passionate. Committed. Your Captain.
  • Home
  • About
    • About Dr. Aaron G. Margulies
    • About Director of Clinical Genetics Services: Imelda G. Margulies MSN, FNP-BC
  • Schedule Appointment
    • Download and Print Patient Forms
      • Dr. Aaron Margulies
        • Breast Care Consultations
        • General Surgery Consultations
      • Imelda Margulies
        • Genetic Counseling and High Risk In Office Consultations
        • Genetic Counseling and High Risk Telehealth Consultations
  • Leave Review
    • Contact
  • Patient Resources
    • Patient Portal
    • Cancer Risk Quiz
    • Dr. Margulies Explains Cancer
    • 5 Questions to ask the Radiologist About Breast Cancer Checklist
    • Hidden Scar Surgery
  • Patient Forms
    • Dr. Aaron Margulies
      • Breast Care Consultations
      • General Surgery Consultations
    • Imelda Margulies
      • Genetic Counseling and High Risk Genetic Counseling and High Risk In Office Consultations Consultations
      • Genetic Counseling and High Risk Telehealth Consultations
  • Cancer Risk Quiz
Search the site...
Home» Breast Cancer Research » More Hope For PARP Inhibitors In Treating Breast Cancer

More Hope For PARP Inhibitors In Treating Breast Cancer

Posted by Dr. Aaron G. Margulies - March 8, 2019 - Breast Cancer Research
0

We hosted a dinner on PARP Inhibitors recently. PARP Inhibitors are a class of medications that may have benefits in Triple Negative and other Breast Cancers in women with a BRCA mutation. Homologous Recombination Deficiencies are associated with several cancers, including breast cancer, and can be identified in breast cancer tissue itself. Tumors with a homologous recombination deficiency (including BRCA mutations) are described as HRD-positive.

When PARP-Inhibitors were introduced as a new class of drugs for the treatment of breast cancer in 2013, we were excited about the potentially life-saving benefits for patients with Triple Negative Breast Cancer.

At the time, we explained how PARP-Inhibitors, or PARP-I, were designed to affect DNA and BRCA mutations. DNA is basically a blueprint for our bodies. Molecules read the DNA and then make the various parts and proteins of our bodies. If the DNA gets broken, then our cells cannot produce what we need and those cells usually die.

The cells that survive will either have an oncogene or a tumor suppressor gene, and these cells will grow uncontrollably and become cancer, most often in breast and ovarian cells. However, there are two ways our cells can fix broken DNA. The first mechanism is the BRCA pathway.

BRCA is a collection of DNA, which is a healthy gene that everyone has in every cell. BRCA has a protein that fixes, or repairs, DNA that is broken. If the BRCA gene is abnormal, which many people understand as BRCA1 and BRCA2, then broken DNA does not get fixed.

Which brings us back to PARP. If the BRCA pathway is broken, then the cell uses another pathway, the PARP (poly ADP ribose polymerase) pathway, to fix the broken DNA. So, if the BRCA cells are abnormal, their DNA can be repaired by PARP so that they can survive and grow uncontrollably, becoming cancer. But if we can inhibit PARP, i.e. use a PARP-I, then an abnormal BRCA cell that might have become cancer cannot repair its DNA and dies.

When introduced six years ago, PARP-Inhibitors had shown effectiveness against Triple Negative Breast Cancers in patients who carry an abnormal BRCA gene in clinical trials. Triple Negative Cancers can be very difficult to kill. But for patients with Triple Negative Cancer and who have a BRCA gene mutation, PARP-Inhibitors may lead to a significant improval in survival.

BRCA, HRD, and PARP-I

Emerging evidence suggests that a significant proportion of patients with BRCA1/BRCA2 type breast cancer are also have what’s called  homologous recombination deficiency (HRD).

HRD is associated with several cancers, including breast and ovarian cancers. Homologous recombination is another DNA repair pathway, so cells that are deficient in homologous recombination may be targeted by PARP inhibitors.

The future is brighter every day, and many dedicated scientists and physicians are searching and studying and experimenting for a cure, every day of every month.

If you’d like to discuss the most successful surgical treatments for breast cancer, I am happy to consult with you. Or, if you’ve recently been diagnosed with breast cancer or are wondering if you should seek a second opinion on your diagnosis or surgical plan, I am also happy to consult with you. I have an office at Tennova Turkey Creek in West Knoxville and an office adjacent to Tennova North Knoxville Medical Center just off of Emory Road in Powell.

My extensive research and dedication to continual learning have distinguished me as a leader in the field of specialized breast cancer oncology. To learn more about my compassionate surgical care approach, visit www.aaronmd.com or call (865) 692-1610.

 

  • Share
  • Facebook
  • Twitter
  • Pinterest
  • Email
  • Print
  • LinkedIn
  • Tumblr
BRCA gene, HRD, PARP-I, Triple Negative Breast Cancer

Dr. Margulies practices sees patients in West Knoxville at Turkey Creek Medical Center, in Powell just off of Emory Road​ adjacent to North Knoxville Medical Center in Powell, at Jefferson Memorial Hospital and Newport Medical Center.

Dr. Margulies performs surgeries at Tennova’s Turkey Creek Medical Center and North Knoxville Medical Center, at Jefferson Memorial Hospital, at Newport Medical Center and at Parkwest Medical Center.

Learn more about Dr. Margulies here.

Hidden Scar Provider

Click here to learn more about Hidden Scar Surgery.

Schedule an Appointment

If you need to request an appointment, please call (865) 692-1610 and ask for Dr. Aaron Margulies.

Connect with Me

  • (865) 692-1610
  • Contact Us
    • Facebook
    • Linkedin
    • Twitter
    • Pinterest
    • Youtube

Patient Testimonials

Your patients are some of the luckiest people in the world. I am so thankful that God brought us together.
Leslie
You are a very wonderful doctor, very kind and sweet. I want to thank you for praying for me before I had my surgery. You don’t find many doctors like you that believe in prayer, I believe in prayer. May God bless you.
Heather
During my cancer journey you and Lisa traveled it with me. Words cannot express my appreciation for all that both of you have done. You both have always encouraged, loved and shown compassion with understanding for me.
Rebecca

Thank you for being the exceptional doctor. By this I mean your thorough explanations, your caring manner and your hugs! I felt completely relaxed in your hands!

Jane
Thanks so much for your help with my cancer, thank God I am well. You are a special person and may God bless you and your staff.
Mary

Recent Articles

  • DCIS Treatment – What Are My Options?
  • What Is Actually Considered “Family History” Or “High Risk” Of Breast Cancer?
  • How Accurate Is Genetic Testing, And When Should You Consider It?
  • How Telemedicine Can Help With Breast Cancer Concerns During COVID-19 
  • What You Need To Know About Surgeries During The COVID-19 Pandemic

Search Articles

Topics

  • Breast Cancer Diagnosis
  • Breast Cancer Research
  • Breast Cancer Surgery
  • Breast Cancer Treatment
  • Cancer Survival
  • Genetic testing
  • Knoxville Community
  • Patient Stories

Resources

  • Abercrombie Radiology
  • American Board of Surgery
  • American College of Surgeons
  • American Society of Breast Surgeons
  • Breast 360
  • Breast Cancer Statistics
  • Breast Cancer Terms
  • Breast Connect
  • Knoxville Comprehensive Breast Center
  • Mastery of Breast Surgery
  • Society of Surgical Oncology
(c) 2020 Dr. Aaron Margulies - Web Design by Baker Labs
  • Home
  • About
  • Schedule Appointment
  • Leave Review
  • Patient Resources
  • Patient Forms
  • Cancer Risk Quiz
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.